 | |
| Formerly | Synthes-Stratec |
|---|---|
| Company type | Subsidiary |
| SIX: SYST | |
| Industry | Health care |
| Founded | 1999 |
| Headquarters | Solothurn, Switzerland (corporate), West Chester, Pennsylvania, United States (operational) |
Key people | Michel Orsinger (president and CEO) |
| Products | Physical trauma, spine, craniofacial, mandible and chest implants, medical power tools, biomaterials |
| Revenue | US $3.687 billion (2010)[1] |
| US $1.283 billion (2010)[1] | |
| US $907.7 million (2010)[1] | |
| Total assets | US $7.924 billion (end 2010)[1] |
| Total equity | US $6.739 billion (end 2010)[1] |
Number of employees | 11,430 (end 2010)[1] |
| Parent | Johnson & Johnson |
| Website | synthes |
Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures,[2] and also produces surgical power tools and advanced biomaterials.
In June 2012 Synthes was sold by its chairman, former CEO and largest shareholder Hansjörg Wyss to Johnson & Johnson for $20.2 billion.[3] The company is part of Johnson & Johnson MedTech business segment.[4]
- ^ a b c d e f "Annual Report 2010". Morningstar.com. Retrieved 9 May 2019.[permanent dead link]
- ^ Lundgren, Kari; Haigh, Adam (21 February 2008). "BAE Systems, BP, Reed Elsevier: U.K., Irish Equity Preview". Bloomberg. Archived from the original on 16 February 2015. Retrieved 2008-06-10.
- ^ "Forbes Profile: Hansjoerg Wyss". Forbes. n.d. Retrieved 9 May 2019.
- ^ "Johnson & Johnson consolidates medtech brands under single banner". FIERCE Biotech. Sep 10, 2024.